Product Code: GDME1388EPD
GlobalData's Medical Devices sector report, "Gastric Bands and Balloons Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Gastric Bands & Balloons pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Medical devices that are used to perform bariatric surgery are referred to as bariatric surgery devices.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Gastric Bands & Balloons under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Gastric Bands & Balloons and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Gastric Bands & Balloons under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Gastric Bands & Balloons Overview
3 Products under Development
- 3.1 Gastric Bands & Balloons - Pipeline Products by Stage of Development
- 3.2 Gastric Bands & Balloons - Pipeline Products by Segment
- 3.3 Gastric Bands & Balloons - Pipeline Products by Territory
- 3.4 Gastric Bands & Balloons - Pipeline Products by Regulatory Path
- 3.5 Gastric Bands & Balloons - Pipeline Products by Estimated Approval Date
- 3.6 Gastric Bands & Balloons - Ongoing Clinical Trials
4 Gastric Bands & Balloons - Pipeline Products under Development by Companies
- 4.1 Gastric Bands & Balloons Companies - Pipeline Products by Stage of Development
- 4.2 Gastric Bands & Balloons - Pipeline Products by Stage of Development
5 Gastric Bands & Balloons Companies and Product Overview
- 5.1 3DT Holdings LLC Company Overview
- 5.2 Allurion Technologies, Inc. Company Overview
- 5.3 Apollo Endosurgery Inc Company Overview
- 5.4 Applied Medical Resources Corporation Company Overview
- 5.5 Asensus Surgical Inc Company Overview
- 5.6 Columbia University Company Overview
- 5.7 CR Bard Inc Company Overview
- 5.8 EndoRetics Inc. Company Overview
- 5.9 EndoVx Inc Company Overview
- 5.10 Gelesis Inc Company Overview
- 5.11 GI Dynamics Inc Company Overview
- 5.12 Hangzhou Tangji Medical Technology Co Ltd Company Overview
- 5.13 Hebrew University of Jerusalem Company Overview
- 5.14 Innovia LLC Company Overview
- 5.15 Johns Hopkins University Company Overview
- 5.16 Mayo Clinic Company Overview
- 5.17 Medi-Globe GmbH Company Overview
- 5.18 MetaModix, Inc Company Overview
- 5.19 Nanyang Technological University Company Overview
- 5.20 Nitinotes Surgical Ltd Company Overview
- 5.21 PandaMed Company Overview
- 5.22 Precision Medical Devices Inc Company Overview
- 5.23 ReShape Lifesciences Inc Company Overview
- 5.24 Satiety Inc (Inactive) Company Overview
- 5.25 Sensate LLC Company Overview
- 5.26 Silhouette Medical Inc Company Overview
- 5.27 SLIMEDICS LTD Company Overview
- 5.28 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview
- 5.29 Tulip Medical Ltd. Company Overview
- 5.30 University of Florida Company Overview
- 5.31 University of Miami Company Overview
- 5.32 ValenTx Inc Company Overview
- 5.33 Vibrynt, Inc. (Inactive) Company Overview
6 Gastric Bands & Balloons- Recent Developments
- 6.1 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
- 6.2 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
- 6.3 May 23, 2022: ReShape Lifesciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
- 6.4 May 18, 2022: Gelesis to Participate in Upcoming Investor Conferences
- 6.5 May 16, 2022: ReShape Lifesciences to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
- 6.6 May 09, 2022: Gelesis to Report First Quarter 2022 Financial Results on May 12, 2022
- 6.7 May 04, 2022: Munson Healthcare Names Primary Care Service Line Medical Director
- 6.8 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
- 6.10 Mar 31, 2022: Vizient Medical Device tech watch provides trends in transcatheter valve replacement and a model for assessing new technology in musculoskeletal care
- 6.11 Mar 31, 2022: ReShape Lifesciences™ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
- 6.12 Mar 28, 2022: ReShape Lifesciences Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update
- 6.13 Feb 10, 2022: TriSalus Life Sciences expands clinical executive team and scientific advisors in support of company's focus to overcome liver and pancreatic cancer treatment barriers and enable more patients to benefit from immunotherapy
- 6.14 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
- 6.15 Nov 11, 2021: ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results
- 6.16 Nov 08, 2021: ReShape Lifesciences to Report Third Quarter 2021 Financial and Operational Results on Thursday, November 11, 2021
- 6.17 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
- 6.18 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
- 6.19 Oct 15, 2021: PENTAX announces expansion of Vizient contract to include pediatric endoscopic products and solutions
- 6.20 Sep 13, 2021: ReShape Lifesciences to Host Exhibit at Bariatric Summit
- 6.21 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer